CNBX Pharmaceuticals Email Format
Pharmaceutical ManufacturingMaryland, United States2-10 Employees
CNBX Pharmaceuticals is a Bethesda-based pharmaceutical manufacturer focused on developing a cannabinoid-based treatment for colorectal cancer. Its lead candidate, CNBX RCC-33, employs a novel, proprietary formulation intended to exert antitumor activity. The company targets the colorectal cancer treatment landscape, aiming to provide a cannabinoid-based therapy that addresses an unmet medical need in oncology. It is publicly traded on the OTCQB under CNBX.